北陆药业：化药板块超预期增长，中成药战略布局趋于完善
Beilu Pharma(300016) 华安证券·2024-09-01 04:30北陆药业（ [Table_StockNameRptType] 300016） 公司点评 化药板块超预期增长，中成药战略布局趋于完善 | --- | --- | --- | |-----------------------------------------------------------------------------------------------|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...